CN102614237B - Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition - Google Patents
Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition Download PDFInfo
- Publication number
- CN102614237B CN102614237B CN2012101122543A CN201210112254A CN102614237B CN 102614237 B CN102614237 B CN 102614237B CN 2012101122543 A CN2012101122543 A CN 2012101122543A CN 201210112254 A CN201210112254 A CN 201210112254A CN 102614237 B CN102614237 B CN 102614237B
- Authority
- CN
- China
- Prior art keywords
- medicinal composition
- chinese medicinal
- parts
- preventing
- medicinal material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases. The Chinese medicinal composition is prepared from the following Chinese herbal medicines in part by weight: 10 to 25 parts of notoginseng root, 10 to 25 parts of szechuan lovage rhizome, 10 to 25 parts of sea horse and 3 to 10 parts of pangolin scales. In addition, the invention also discloses a preparation method for the Chinese medicinal composition. The Chinese medicinal composition is safe and convenient to use, and does not have toxic or side effect; and compared with the conventional 'Chinese patent medicine', the Chinese medicinal composition has the advantages that a curative effect is reliable and obvious; hemorrhagic diseases (the thrombocytopenic problem) are not caused when the Chinese medicinal composition is used; the Chinese medicinal composition has the effects of promoting blood circulation, eliminating stasis (dissolving thrombus), promoting qi circulation and blood (removing thrombus), dispelling wind and dredging collaterals, and mainly has the double effects of dissolving 'thrombus' quickly, softening blood vessels, dissolving thrombus and stopping bleeding; and an effect of improving cardio-cerebral renal microcirculation is obvious, syndromes which occur before cardiovascular, cerebrovascular and renovascular diseases come on can be prevented and treated fundamentally, senility can be delayed, and the total effective rate is more than 97 percent.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of Chinese medicine composition of preventing and treating heart brain and kidney blood vessel diseases and preparation method thereof.
Background technology
Heart brain and kidney blood vessel diseases is a kind of serious harm mankind, and particularly the commonly encountered diseases of middle-aged and elderly people health more than 50 years old, even apply most advanced, perfect at present treatment means, still can have the cerebrovascular accident survivor life more than 50% not take care of oneself fully.Every year is died from the number of heart brain and kidney blood vessel diseases up to 1,500 ten thousand people in the whole world, occupies various causes of the death first place.China dies from nearly 3,000,000 people of heart brain and kidney blood vessel diseases every year, accounts for 51% of the annual total Death causes of China.And the patient 75% who survives disability in various degree, wherein 40% is heavy residual.The leave hospital relapse rate of rear First Year of China's patient with cerebral apoplexy is that the relapse rate of 30%, the five year is up to 59%.
The pharmacotherapy of control heart brain and kidney blood vessel diseases (oral or injection) adopts the medicines of dispelling wind and removing obstruction in the collateral, blood circulation promoting and blood stasis dispelling more at present, though these medicines have certain curative effect, slow for the thrombolytic effect of heart brain and kidney blood vessel diseases, curative effect is remarkable not.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of safety for above-mentioned the deficiencies in the prior art, easy to use, have no side effect for preventing and treating the Chinese medicine composition of heart brain and kidney blood vessel diseases.Chinese medicine composition of the present invention is compared with existing " Chinese patent medicine ", curative effect is reliable, can causing bleeding property disease (thrombocytopenic problem) during use, effect with promoting blood circulation to remove blood stasis (thrombolytic), circulation of qi promoting promoting the circulation of blood (row's bolt), dispelling wind and removing obstruction in the collateral, mainly contain and dissolve " thrombosis " soon, the double effects of vessel softening thrombolytic hemostasis, improve the effect of heart and brain renal microcirculation very obvious, can fundamentally prevent and treat the syndrome that heart and brain kidney blood vessel premorbid occurs, evident in efficacy, and the energy slow down aging, its total effective rate is more than 97%.
For solving the problems of the technologies described above, the technical solution used in the present invention is: a kind of Chinese medicine composition of preventing and treating heart brain and kidney blood vessel diseases, it is characterized in that, and by the crude drug of following weight portion, made:
Radix Notoginseng 10-25 part Rhizoma Chuanxiong 10-25 part Hippocampus 10-25 part
Squama Manis 3-10 part.
Optimal technical scheme of the present invention is: a kind of Chinese medicine composition of preventing and treating heart brain and kidney blood vessel diseases, it is characterized in that, and by the crude drug of following weight portion, made:
Radix Notoginseng 15-18 part Rhizoma Chuanxiong 15-18 part Hippocampus 15-18 part
Squama Manis 6-8 part.
Best-of-breed technology scheme of the present invention is: a kind of Chinese medicine composition of preventing and treating heart brain and kidney blood vessel diseases, it is characterized in that, and by the crude drug of following weight portion, made: 17 parts of Radix Notoginseng, 17 parts of Rhizoma Chuanxiongs, 17 parts of Hippocampus, 7 parts of Squama Maniss.
The present invention also provides the preparation method of the Chinese medicine composition of above-mentioned control heart brain and kidney blood vessel diseases, it is characterized in that, the method comprises the following steps:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 30min～60min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, powder described in step 2 is made to powder, tablet, capsule, pill or electuary according to a conventional method.
Described weight portion can be the weight metering units such as gram, two, jin, kilogram, ton.
The present invention, with reference to the reason of " control wind and first control blood, blood wind is from going out, and the stagnation of QI is blood clotting, the capable blood of gas ", selects Radix Notoginseng, Rhizoma Chuanxiong, Hippocampus and Squama Manis formulated.In side of the present invention, Radix Notoginseng is monarch drug, warm in nature, has dissipating blood stasis (thrombolytic) hemostasis, and the effect of subduing swelling and relieving pain, can be used for treating the cardiovascular diseases; Rhizoma Chuanxiong is ministerial drug, warm in nature, has (thrombolytic) circulation of qi promoting of invigorating blood circulation, and the effect of wind-expelling pain-stopping, can be used for treating cerebrovascular; Hippocampus is adjuvant drug, warm in nature, has kidney invigorating and YANG supporting, and the effects such as promoting blood circulation to remove blood stasis (thrombolytic), for soreness of the waist and knees, sexual impotence, frequent micturition, traumatic hemorrhage etc. due to kidney yang deficiency, can be used for treating renal vascular disease; Squama Manis is for making medicine, and cold nature, have the latus rectum stimulating milk secretion, and the effects such as eliminating stasis and resolving masses (thrombolytic) can be dredged the blood vessel at any position of whole body.The present invention selects that Radix Notoginseng, Rhizoma Chuanxiong, Hippocampus and Squama Manis match, bring out the best in each other, the effect multiplication, and not only thrombolytic but also stop blooding again can causing bleeding property disease, thereby has softening heart and brain kidney blood vessel, and thrombolytic is fast, and the time is short, the characteristics such as safe ready.
The present invention is complete, and side has the effect of promoting blood circulation to remove blood stasis (thrombolytic), circulation of qi promoting promoting the circulation of blood (row's bolt), dispelling wind and removing obstruction in the collateral, mainly contains and dissolves " thrombosis " soon, the double effects of vessel softening thrombolytic hemostasis.
The present invention compared with prior art has the following advantages:
1, the invention belongs to pure Chinese medicinal preparation, safe and reliable, have no side effect, with similar drugs, compare, there is cost low, curative effect is high, the characteristics of instant effect.
2, Chinese medicine composition safety of the present invention, easy to use, have no side effect, with existing " Chinese patent medicine ", compare, curative effect is reliable, can causing bleeding property disease (thrombocytopenic problem) during use, there is promoting blood circulation to remove blood stasis (thrombolytic), circulation of qi promoting promoting the circulation of blood (row's bolt), the effect of dispelling wind and removing obstruction in the collateral, mainly contain and dissolve " thrombosis " soon, the double effects of vessel softening thrombolytic hemostasis, improve the effect of heart and brain renal microcirculation very obvious simultaneously, can fundamentally prevent and treat the syndrome that heart and brain kidney blood vessel premorbid occurs, evident in efficacy, and energy slow down aging, its total effective rate reaches more than 97%.
3, the present invention adopts ultrasonic heat backflow extraction concentration group to be extracted respectively the effective ingredient in medical material, and technique is simple, easy to operate, and in medical material, the effective ingredient yield is high.
Below by embodiment, technical scheme of the present invention is described in further detail.
The specific embodiment
Embodiment 1
The present embodiment crude drug used is Radix Notoginseng 10g, Rhizoma Chuanxiong 10g, Hippocampus 10g, Squama Manis 3g.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material, is the alcohol-pickled 60min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by powder described in step 2 routinely the method for powder processed make thrombolytic powder, pack, every bag containing crude drug 0.6g.
Embodiment 2
The present embodiment crude drug used is Radix Notoginseng 25g, Rhizoma Chuanxiong 25g, Hippocampus 25g, Squama Manis 10g.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 30min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by powder described in step 2 routinely the method tabletting of film-making agent make thrombolytic tablets, every containing crude drug 0.3g.
Embodiment 3
The present embodiment crude drug used is Radix Notoginseng 15g, Rhizoma Chuanxiong 15g, Hippocampus 15g, Squama Manis 6g.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 40min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by powder described in step 2 routinely the method for pill agent make Thrombolytic Pill, every ball is containing crude drug 0.6g.
Embodiment 4
The present embodiment crude drug used is Radix Notoginseng 18g, Rhizoma Chuanxiong 18g, Hippocampus 18g, Squama Manis 8g.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 60min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by powder described in step 2 routinely the method for electuary processed make the thrombolytic electuary, pack, every bag containing crude drug 0.6g.
Embodiment 5
The present embodiment crude drug used is Radix Notoginseng 17g, Rhizoma Chuanxiong 17g, Hippocampus 17g, Squama Manis 7g.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 30min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by the encapsulated RONGSHUAN JIAONANG of making of method of glue wafer routinely of powder described in step 2, every containing crude drug 0.3g.
Embodiment 6
The present embodiment crude drug used is Radix Notoginseng 20kg, Rhizoma Chuanxiong 15kg, Hippocampus 20kg, Squama Manis 9kg.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 60min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by the encapsulated RONGSHUAN JIAONANG of making of method of glue wafer routinely of powder described in step 2, every containing crude drug 0.3g.
Embodiment 7
The present embodiment crude drug used is Radix Notoginseng 18kg, Rhizoma Chuanxiong 15kg, Hippocampus 16kg, Squama Manis 6kg.
The preparation method of the present embodiment is as follows:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 50min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group (this ultrasonic heat backflow extraction concentration group is purchased from Qihe Shandong power medication chemistry equipment installation project company limited) are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, by powder described in step 2 routinely the method tabletting of film-making agent make thrombolytic tablets, every containing crude drug 0.3g.
The research that the thrombolytic effect of Chinese medicine composition of the present invention is carried out, the old people that 228 routine 56-82 years were suffered to heart brain and kidney blood vessel diseases randomly draws venous blood, the multi-ring thrombometer acquisition abnormity of the MR-4 type thrombosis that employing is developed by the Shanghai research in new high-tech is as specimen, pack in plastic bottle, put into refrigerator freezing and save backup, adopt respectively the fragrant thrombus-resisting capsules of the stasis of blood, XINNAOKANG JIAONANG, FUFANG DANSHEN PIAN, NAOLUOTONG JIAONANG, TONGXINLUO JIAONANG and RONGSHUAN JIAONANG of the present invention to carry out the thrombolytic test to the thrombosis specimen of preserving; Concrete test method is: respectively the medicated powder in the fragrant thrombus-resisting capsules of the stasis of blood, XINNAOKANG JIAONANG, NAOLUOTONG JIAONANG, TONGXINLUO JIAONANG and RONGSHUAN JIAONANG of the present invention is taken out, FUFANG DANSHEN PIAN is ground to form to medicated powder; Take respectively various medicated powder 2.0g and be placed in respectively different beakers, put 3 millimeters long thrombosis specimen to respectively cutting in beaker, then respectively add the warm water 30mL that temperature is 58 ℃～62 ℃ in beaker, put into thermostatic water tank after shaking up respectively, shake up observation once every 10min, record thrombosis specimen solution time.
The experimental observation standard: the time that the absorption according to medicine in human body, distribution, metabolism, row thank, the time that will dissolve thrombosis is set as take in 3 hours the interior person of melting away as produce effects, and in 5 hours, the person of melting away is that effectively more than 6 hours, the person of dissolving is invalid.
Result of the test: adopt RONGSHUAN JIAONANG of the present invention to carry out the thrombolytic test, in 228 routine patients, the thrombosis specimen of 1 86 examples was dissolved fully in 3 hours, obvious effective rate reaches 81.6%, the thrombosis specimen of 39 examples was dissolved fully in 5 hours, total effective rate reached the thrombosis specimen solution time of 98.7%, 3 example over 6 hours.It is short that thrombolytic group is dissolved thrombosis successful, time.And adopting the fragrant thrombus-resisting capsules of the stasis of blood, XINNAOKANG JIAONANG, NAOLUOTONG JIAONANG and TONGXINLUO JIAONANG to carry out the thrombolytic test, 228 routine patients' thrombosis specimen had no significant change more than 24 hours.Illustrate and adopt RONGSHUAN JIAONANG of the present invention instantizing thrombosis soon, the thrombolytic total effective rate reaches 98.7%, dissolves the thrombosis time obviously faster than other Chinese patent medicines, and very important research promotion and practical value are arranged.
Usage and dosage of the present invention: powder is taken three times every day, each 1～2 bag, uses after meal warm water delivery service; Tablet is taken three times every day, each 2～4, uses after meal warm water delivery service; Capsule is taken three times every day, each 2～4, uses after meal warm water delivery service; Pill is taken three times every day, and each 1～2 ball, use warm water delivery service after meal; Electuary is taken three times every day, each 1～2 bag, uses after meal warm boiled water.
The heart brain and kidney blood vessel diseases diagnostic criteria: diagnosis was with national TCM diagnostic criteria in 1989.
Cure: more than hemiplegic limb Myodynamia recovery to 4～5 grade, the objective determination index has the recuperator;
Produce effects: hemiplegic patient's limbs recover 2 more than level, the objective determination index person of being improved;
Effectively: hemiplegic limb recovers 1 level, and objective indicator is improved;
Invalid: 2～4 courses for the treatment of, the primary symptom sign is without the improver.
Clinical observation case 894 examples of the present invention, treatment group 684 examples wherein, male 301 examples, female's 383 examples, 24～78 years old age, the course of disease 2～16 years, apoplex involving the channels and collaterals 492 examples, Hitting Viscera 192 examples; In treatment group: 18 examples forecast through apoplexy, and 366 examples are through computed tomography brain scan, and 186 examples are made a definite diagnosis contrast through cerebral blood flow and lipid examination; Matched group 210 examples, male 78 examples, female's 132 examples, 40～75 years old age, the course of disease 2～3 years, apoplex involving the channels and collaterals 144 examples, Hitting Viscera 66 examples; Treatment group adopts Chinese medicine composition of the present invention (capsule), and each 2～4 15 days is a course for the treatment of, brief summary after 2～4 courses for the treatment of; Matched group adopts conventional medicine " musk capsule for anti-thrombus ", and each 4 every day 3 times, 15 days is a course for the treatment of, brief summary after 2～4 courses for the treatment of.The same state of an illness, same time limit, treatment group and treatment of control group fore-and-aft observing blood pressure, rheoencephalogram, a blood fat complete set, skull CT scanning, neural reflex, limb activities etc., take the limbs doing well,improving as main, relatively, its result is general curative effect: in treatment group 684 examples, cure 132 examples, account for 19.3%, produce effects 234 examples, account for 34.2%, effective 298 examples, account for 43.6%, invalid 20 examples, account for 2.9%, total effective rate 97.1%; In matched group 210 examples, cure 24 examples, account for 11.4%, produce effects 45 examples, account for 21.4%, and effective 117 examples, account for 55.7%, and invalid 24 examples, account for 11.4%, total effective rate 88.6%.Two groups of curative effects relatively have notable difference.
Model case:
1, horse * *, the female, 41 years old, 6, Dai Shu of 05 on December: January cause overwork at 2 o'clock in afternoon the self-induction right lower extremity ice-cold, then right hemiplegia and aphasia stupor; Through skull CT scanning, examine as " cerebral hemorrhage " amount of bleeding: 20mL; Gradually clear by two weeks rear mind of the treatments such as Western medicine liquid, oxygen uptake.Body is looked into: 37.7 degrees centigrade of body temperature, BP:140/90mmHg, apathetic expression, right Hoffmanns sign (+), tendon hyperreflexia, muscular strength I level; Tongue is dark red, the white and thin fur thready and hesitant pulse; Card belongs to: the apoplexy blood stasis type of deficiency of YIN leading to hyper activity of YANG of holding concurrently; Examine as cerebral hemorrhage right avertence paralysis, control with dispelling wind and removing obstruction in the collateral promoting blood circulation to remove blood stasis, circulation of qi promoting promoting the circulation of blood; Each 4 of oral RONGSHUAN JIAONANG of the present invention, every day 3 times, can send out microphony next day, and after one week, language is normal; Muscular strength II level, muscular strength V level after January, all cards disappear, and follow up a case by regular visits to not recurrence after 5 years.
2, Lee * *, the female, 55 years old, on May 8th, 08 was stated, before one week, to play conscious left side health stiff morning, hospitalization, through skull CT scanning, examine as " cerebral infarction ", body is looked into: 37 degrees centigrade of body temperature, blood pressure: 130/70mmHg, expression is painful, the left bar of left Hoffmanns sign (+) Bin Shi Ji Shi levies (+), muscular strength I level, tongue is dark red, the tongue the lung-pulse is thin, card belongs to: the apoplexy blood stasis type, examine as cerebral infarction (left avertence paralysis), control with promoting blood circulation to remove blood stasis, the circulation of qi promoting promoting the circulation of blood, dispelling wind and removing obstruction in the collateral, each 4 of oral RONGSHUAN JIAONANG of the present invention, every day 3 times, muscular strength II level after two weeks, and leave hospital, continue to take RONGSHUAN JIAONANG treatment of the present invention, after March, follow up a case by regular visits to, all cards disappear, follow up a case by regular visits to not recurrence after 3 years.
3, Lee * *, the female, 53 years old, examined in April, 07, the main suit: dizziness, nervous, uncomfortable in chest, insomnia, lumbago, accompanied with hypertension is more than 2 years; Look into: BP152/96mmHg, cholesterol 6.2mmol/L, triglyceride 2.4mmol/L; Electrocardiogram prompting: arrhythmia; Pale tongue with thin fur is white, stringy and rolling pulse; Examine as hypertension, hyperlipemia, coronary heart disease; Card belongs to: type of failure of the heart and kidney integrating, control with promoting blood circulation to remove blood stasis, circulation of qi promoting promoting the circulation of blood each 3 of oral RONGSHUAN JIAONANG of the present invention, every day 3 times; The bimester after check: BP:132/84mmHg, cholesterol 4.8mmol/L, triglyceride 1.5mmol/L; Transference cure, follow up a case by regular visits to not recurrence after half a year.
The above; it is only preferred embodiment of the present invention; not the present invention is imposed any restrictions, every any simple modification of above embodiment being done according to the technology of the present invention essence, change and equivalent structure change, and all still belong in the protection domain of technical solution of the present invention.
Claims (4)
1. a Chinese medicine composition of preventing and treating cardiovascular and cerebrovascular disease, is characterized in that, by the crude drug of following weight portion, made:
Radix Notoginseng 10-25 part Rhizoma Chuanxiong 10-25 part Hippocampus 10-25 part
Squama Manis 3-10 part.
2. a kind of Chinese medicine composition of preventing and treating cardiovascular and cerebrovascular disease according to claim 1, is characterized in that, by the crude drug of following weight portion, made:
Radix Notoginseng 15-18 part Rhizoma Chuanxiong 15-18 part Hippocampus 15-18 part
Squama Manis 6-8 part.
3. a kind of Chinese medicine composition of preventing and treating cardiovascular and cerebrovascular disease according to claim 2, is characterized in that, by the crude drug of following weight portion, made: 17 parts of Radix Notoginseng, 17 parts of Rhizoma Chuanxiongs, 17 parts of Hippocampus, 7 parts of Squama Maniss.
4. the method prepared as the Chinese medicine composition of control cardiovascular and cerebrovascular disease as described in claim 1,2 or 3, is characterized in that, the method comprises the following steps:
Step 1, taking each raw medicinal material by weight, is the alcohol-pickled 30min～60min more than 95% by mass concentration respectively by the raw medicinal material taken, and after taking out, naturally dries;
Step 2, employing ultrasonic heat backflow extraction concentration group are extracted respectively the raw medicinal material after drying in step 1, and making granularity after the product after extracting is mixed is 200～300 purpose powder;
Step 3, powder described in step 2 is made to powder, tablet, capsule, pill or electuary according to a conventional method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101122543A CN102614237B (en) | 2012-04-17 | 2012-04-17 | Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101122543A CN102614237B (en) | 2012-04-17 | 2012-04-17 | Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102614237A CN102614237A (en) | 2012-08-01 |
| CN102614237B true CN102614237B (en) | 2013-12-04 |
Family
ID=46554686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101122543A Expired - Fee Related CN102614237B (en) | 2012-04-17 | 2012-04-17 | Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102614237B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1565606A (en) * | 2003-06-30 | 2005-01-19 | 高希臣 | Chinese drug with functions of regulating blood lipid and treating cardiovascular and cerebrovascular disease |
-
2012
- 2012-04-17 CN CN2012101122543A patent/CN102614237B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1565606A (en) * | 2003-06-30 | 2005-01-19 | 高希臣 | Chinese drug with functions of regulating blood lipid and treating cardiovascular and cerebrovascular disease |
Non-Patent Citations (5)
| Title |
|---|
| 上海矩源机械设备有限公司.超声波动态热回流提取浓缩机组.《中国食品机械网》.2009,第1页. * |
| 张丰强.川芎.《临床大本草》.2002,第576-579页. * |
| 罗傲雪等.超声波辅助热回流技术提取马鞭石斛多糖的工艺研究.《时珍国医国药》.2009,第20卷(第10期),第2522页-2524页. |
| 超声波辅助热回流技术提取马鞭石斛多糖的工艺研究;罗傲雪等;《时珍国医国药》;20091020;第20卷(第10期);第2522页-2524页，正文第二部分2.1方法 * |
| 郑宏钧等.海马.《现代中药材鉴别手册》.2001,第982-985页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102614237A (en) | 2012-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102133288B (en) | Chinese herbal preparation for curing angina | |
| CN101816712B (en) | Chinese medicinal composition for treating trigeminal neuralgia | |
| CN102614237B (en) | Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition | |
| CN103550477B (en) | Medicament for treating herpes zoster | |
| CN100333779C (en) | Chinese medicine prepn for treating vaginitis and cervicitis | |
| CN103656239B (en) | A kind of Chinese drugs agentia for the treatment of wind syndrome of head and preparation method thereof | |
| CN102940677B (en) | Medicine composition for treating diabetic foot | |
| CN102552724B (en) | Chinese medicine composite for curing hypertension | |
| CN102274357B (en) | Pharmaceutical composition for treating coronary arteriosclerotic heart disease and preparation method thereof | |
| CN103599397B (en) | A kind of Chinese medicine composition being used for the treatment of chronic renal insufficiency | |
| CN104689092B (en) | A kind of medicine for treating apoplexy | |
| CN108743757A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating insomnia | |
| CN103405660A (en) | Compound medicine for treating headache | |
| CN103349709B (en) | Traditional Chinese medicine preparation capable of tonifying qi and yin and nourishing liver and kidney | |
| CN101391045B (en) | Traditional Chinese medicine compound preparation for treating migraine and general headache and preparation method thereof | |
| CN102657820B (en) | Traditional Chinese medicine for treating cerebral infarction | |
| CN1321653C (en) | Drink for relaxing muscles and stimulating blood circulation | |
| CN107693621A (en) | Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment | |
| CN101642536B (en) | Plaster for treating hyperosteogeny | |
| CN101607007B (en) | Traditional Chinese medicine preparation for treating cerebral circulation insufficiency | |
| CN101732425A (en) | Externally-applied medicine composite for psoriasis | |
| CN105012546A (en) | Sanhuang foot bath bag for curing diabetic foot and use method thereof | |
| CN106138618B (en) | A pharmaceutical composition for treating angina pectoris, and its preparation method | |
| CN104491764A (en) | Medicine composition used for treating anus eczema | |
| CN113069503A (en) | Foot bath medicine for treating heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 Termination date: 20150417 |
|
| EXPY | Termination of patent right or utility model |